Tumor suppressor microRNA-34a inhibits cell proliferation by targeting notch1 in renal cell carcinoma

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1689-1694

  Zhang, Changcun ^a   Mo, Ren ^a   Yin, Binde ^a   Zhou, Libin ^a   Liu, Yongchao ^a   Fan, Jie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Cell cycle; Cell proliferation; Microrna 34a; Notch1; Renal cell carcinoma; Target oncogenes

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYCLIN E; MESSENGER RNA; MICRORNA 34A; NOTCH1 RECEPTOR; SIRTUIN 1; TRANSCRIPTION FACTOR E2F3;

ADULT; AGED; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNTING; CELL CYCLE ARREST; CELL CYCLE ASSAY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RNA EXTRACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84896270599     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1931     Document Type: Article

References (32)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281&2011;297, 2004.
2. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
3. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
4. Zhou L, Yin B, Liu Y, Hong Y, Zhang C and Fan J: Mechanism and function of decreased FOXO1 in renal cell carcinoma. J Surg Oncol 105: 841-847, 2012.
5. Liu Y, Yin B, Zhang C, Zhou L and Fan J: Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochem Biophys Res Commun 417: 371-375, 2012.
6. Chang TC, Wentzel EA, Kent OA, et al: Transactivation of miR-34a by p53 broadly infl uences gene expression and promotes apoptosis. Mol Cell 26: 745-752, 2007.
7. Yamamura S, Saini S, Majid S, et al: MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 7: e29722, 2012.
8. Gallardo E, Navarro A, Viñolas N, et al: miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30: 1903-1909, 2009.
9. He L, He X, Lim LP, et al: A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007.
10. Hermeking H: p53 enters the microRNA world. Cancer Cell 12: 414-418, 2007.
11. Sun F, Fu H, Liu Q, et al: Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582: 1564-1568, 2008.
12. Welch C, Chen Y and Stallings RL: MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022, 2007.
13. Tazawa H, Tsuchiya N, Izumiya M and Nakagama H: Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104: 15472-15477, 2007.
14. Pang RT, Leung CO, Ye TM, et al: MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 31: 1037-1044, 2010.
15. Li WB, Ma MW, Dong LJ, Wang F, Chen LX and Li XR: MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol Ther 12: 477-483, 2011.
16. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often fl anked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
17. Yamakuchi M, Ferlito M and Lowenstein CJ: miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105: 13421-13426, 2008.
18. Bolós V, Grego-Bessa J and de la Pompa JL: Notch signaling in development and cancer. Endocr Rev 28: 339-363, 2007.
19. Tohda S and Nara N: Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 42: 467-472, 2001.
20. Reedijk M, Odorcic S, Chang L, et al: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537, 2005.
21. Wang Z, Zhang Y, Li Y, Banerjee S, Liao J and Sarkar FH: Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 5: 483-493, 2006.
22. Ai Q, Ma X, Huang Q, et al: High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma. PLoS One 7: e35022, 2012.
23. Sjölund J, Boström AK, Lindgren D, et al: The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma. PLoS One 6: e23057, 2011.
24. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
25. Kaghad M, Bonnet H, Yang A, et al: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997.
26. Wei JS, Song YK, Durinck S, et al: The MYCN oncogene is a direct target of miR-34a. Oncogene 27: 5204-5213, 2008.
27. Reiter RE, Anglard P, Liu S, Gnarra JR and Linehan WM: Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53: 3092-3097, 1993.
28. Lodygin D, Tarasov V, Epanchintsev A, et al: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600, 2008.
29. Xu L, Zhu Y, Xu J, et al: Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling. Cancer Sci 103: 1253-1258, 2012.
30. Du R, Sun W, Xia L, et al: Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 7: e30771, 2012.
31. Bueno MJ and Malumbres M: MicroRNAs and the cell cycle. Biochim Biophys Acta 1812: 592-601, 2011.
32. Nana-Sinkam SP and Croce CM: MicroRNAs as therapeutic targets in cancer. Transl Res 157: 216-225, 2011.